Quviviq

Active Ingredient(s): Daridorexant
FDA Approved: * January 7, 2022
Pharm Company: * IDORSIA PHARMACEUTICALS LTD.
Category: Sleep Aid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Quviviq Overview

Daridorexant, sold under the brand name Quviviq, is a medication used for the treatment of insomnia.[1] Daridorexant is a dual orexin receptor antagonist (DORA) which was originated by Actelion Pharmaceuticals and is under development by Idorsia Pharmaceuticals.[3][4] It acts as a selective dual antagonist of the orexin receptors OX1 and OX2.[3][4] The medication has a relatively short elimination half-life of 6 t...

Read more Quviviq Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Daridorexant

Recent Quviviq Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Daridorexant
  • Tablet: 25mg, 50mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Daridorexant or a similar ingredient: (1 result)